img

Global and United States Intelligent Drug R-D Services Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Software

Publisher : MRA | Format : PDF

Global and United States Intelligent Drug R-D Services Market Report & Forecast 2024-2034

Leading biopharmaceutical companies believe in AI due to growing awareness in the pharmaceutical sector and rising investment in drug development. AI works with the latest advanced biology and chemistry processes to develop state-of-the-art algorithms; it has the potential to move drug screening from the bench to a virtual lab without the need for extensive experimental input and manpower.Most biopharmaceutical companies have started internal programs or are collaborating to develop AI platforms for increasing the research power of immuno-oncology drugs, metabolic-disease therapies, cancer treatments, and many other therapeutic targets.
Market Analysis and InsightsGlobal and United States Intelligent Drug R-D Services Market
This report focuses on global and United States Intelligent Drug R-D Services market, also covers the segmentation data of other regions in regional level and county level.
The global Intelligent Drug R-D Services revenue was US$ 1200 million in 2023 and is forecast to a readjusted size of US$ 6558.6 million by 2033 with a CAGR of 28.6% during the review period (2023-2033).
In United States the Intelligent Drug R-D Services revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Intelligent Drug R-D Services include BenevolentAI, Exscientia, IBM, Alphabet, Berg Health, Atomwise, Insitro, Cyclica and NVIDIA, etc. The global five biggest players hold a share of % in 2023.
Global Intelligent Drug R-D Services Scope and Market Size
Intelligent Drug R-D Services market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Intelligent Drug R-D Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Intelligent Drug R-D Services market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


BenevolentAI
Exscientia
IBM
Alphabet
Berg Health
Atomwise
Insitro
Cyclica
NVIDIA
Insilico Medicine
AstraZeneca
CAPGEMINI ENGINEERING
Hafnium Labs ApS
XtalPi Inc
Schrödinger
Charles River Laboratories
IQVIA Inc
Healx
Innoplexus
EVAXION BIOTECH A/S
Icometrix
Segment by Type
Cloud Based
On-Premise

Segment by Application


Drug Discovery Research
Drug Development Research
Clinical Research
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Intelligent Drug R-D Services definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Intelligent Drug R-D Services companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Intelligent Drug R-D Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intelligent Drug R-D Services revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Intelligent Drug R-D Services Product Introduction
1.2 Global Intelligent Drug R-D Services Outlook 2018 VS 2023 VS 2033
1.2.1 Global Intelligent Drug R-D Services Market Size for the Year 2018-2033
1.2.2 United States Intelligent Drug R-D Services Market Size for the Year 2018-2033
1.3 Intelligent Drug R-D Services Market Size, United States VS Global, 2018 VS 2023 VS 2033
1.3.1 The Market Share of United States Intelligent Drug R-D Services in Global, 2018 VS 2023 VS 2033
1.3.2 The Growth Rate of Intelligent Drug R-D Services Market Size, United States VS Global, 2018 VS 2023 VS 2033
1.4 Intelligent Drug R-D Services Market Dynamics
1.4.1 Intelligent Drug R-D Services Industry Trends
1.4.2 Intelligent Drug R-D Services Market Drivers
1.4.3 Intelligent Drug R-D Services Market Challenges
1.4.4 Intelligent Drug R-D Services Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Intelligent Drug R-D Services by Type
2.1 Intelligent Drug R-D Services Market Segment by Type
2.1.1 Cloud Based
2.1.2 On-Premise
2.2 Global Intelligent Drug R-D Services Market Size by Type (2018, 2023 & 2033)
2.3 Global Intelligent Drug R-D Services Market Size by Type (2018-2033)
2.4 United States Intelligent Drug R-D Services Market Size by Type (2018, 2023 & 2033)
2.5 United States Intelligent Drug R-D Services Market Size by Type (2018-2033)
3 Intelligent Drug R-D Services by Application
3.1 Intelligent Drug R-D Services Market Segment by Application
3.1.1 Drug Discovery Research
3.1.2 Drug Development Research
3.1.3 Clinical Research
3.2 Global Intelligent Drug R-D Services Market Size by Application (2018, 2023 & 2033)
3.3 Global Intelligent Drug R-D Services Market Size by Application (2018-2033)
3.4 United States Intelligent Drug R-D Services Market Size by Application (2018, 2023 & 2033)
3.5 United States Intelligent Drug R-D Services Market Size by Application (2018-2033)
4 Global Intelligent Drug R-D Services Competitor Landscape by Company
4.1 Global Intelligent Drug R-D Services Market Size by Company
4.1.1 Global Key Companies of Intelligent Drug R-D Services, Ranked by Revenue (2023)
4.1.2 Global Intelligent Drug R-D Services Revenue by Player (2018-2023)
4.2 Global Intelligent Drug R-D Services Concentration Ratio (CR)
4.2.1 Intelligent Drug R-D Services Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Intelligent Drug R-D Services in 2023
4.2.3 Global Intelligent Drug R-D Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Intelligent Drug R-D Services Head office and Area Served
4.4 Global Key Players of Intelligent Drug R-D Services, Product and Application
4.5 Global Key Players of Intelligent Drug R-D Services, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Intelligent Drug R-D Services Market Size by Company
4.7.1 Key Players of Intelligent Drug R-D Services in United States, Ranked by Revenue (2023)
4.7.2 United States Intelligent Drug R-D Services Revenue by Players (2021, 2023 & 2023)
5 Global Intelligent Drug R-D Services Market Size by Region
5.1 Global Intelligent Drug R-D Services Market Size by Region: 2018 VS 2023 VS 2033
5.2 Global Intelligent Drug R-D Services Market Size by Region (2018-2033)
5.2.1 Global Intelligent Drug R-D Services Market Size by Region: 2018-2023
5.2.2 Global Intelligent Drug R-D Services Market Size by Region (2024-2033)
6 Americas
6.1 Americas Intelligent Drug R-D Services Market Size YoY Growth 2018-2033
6.2 Americas Intelligent Drug R-D Services Market Size by Type
6.2.1 Americas Intelligent Drug R-D Services Market Size by Type (2018-2023)
6.2.2 Americas Intelligent Drug R-D Services Market Size by Type (2024-2033)
6.2.3 Americas Intelligent Drug R-D Services Market Share by Type (2018-2033)
6.3 Americas Intelligent Drug R-D Services Market Size by Application
6.3.1 Americas Intelligent Drug R-D Services Market Size by Application (2018-2023)
6.3.2 Americas Intelligent Drug R-D Services Market Size by Application (2024-2033)
6.3.3 Americas Intelligent Drug R-D Services Market Share by Application (2018-2033)
6.4 Americas Intelligent Drug R-D Services Market Facts & Figures by Country (2018, 2023 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Intelligent Drug R-D Services Market Size YoY Growth 2018-2033
7.2 EMEA Intelligent Drug R-D Services Market Size by Type
7.2.1 EMEA Intelligent Drug R-D Services Market Size by Type (2018-2023)
7.2.2 EMEA Intelligent Drug R-D Services Market Size by Type (2024-2033)
7.2.3 EMEA Intelligent Drug R-D Services Market Share by Type (2018-2033)
7.3 EMEA Intelligent Drug R-D Services Market Size by Application
7.3.1 EMEA Intelligent Drug R-D Services Market Size by Application (2018-2023)
7.3.2 EMEA Intelligent Drug R-D Services Market Size by Application (2024-2033)
7.3.3 EMEA Intelligent Drug R-D Services Market Share by Application (2018-2033)
7.4 EMEA Intelligent Drug R-D Services Market Facts & Figures by Country (2018, 2023 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Intelligent Drug R-D Services Market Size YoY Growth 2018-2033
8.2 China Intelligent Drug R-D Services Market Size by Type
8.2.1 China Intelligent Drug R-D Services Market Size by Type (2018-2023)
8.2.2 China Intelligent Drug R-D Services Market Size by Type (2024-2033)
8.2.3 China Intelligent Drug R-D Services Market Share by Type (2018-2033)
8.3 China Intelligent Drug R-D Services Market Size by Application
8.3.1 China Intelligent Drug R-D Services Market Size by Application (2018-2023)
8.3.2 China Intelligent Drug R-D Services Market Size by Application (2024-2033)
8.3.3 China Intelligent Drug R-D Services Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Intelligent Drug R-D Services Market Size YoY Growth 2018-2033
9.2 APAC Intelligent Drug R-D Services Market Size by Type
9.2.1 APAC Intelligent Drug R-D Services Market Size by Type (2018-2023)
9.2.2 APAC Intelligent Drug R-D Services Market Size by Type (2024-2033)
9.2.3 APAC Intelligent Drug R-D Services Market Share by Type (2018-2033)
9.3 APAC Intelligent Drug R-D Services Market Size by Application
9.3.1 APAC Intelligent Drug R-D Services Market Size by Application (2018-2023)
9.3.2 APAC Intelligent Drug R-D Services Market Size by Application (2024-2033)
9.3.3 APAC Intelligent Drug R-D Services Market Share by Application (2018-2033)
9.4 APAC Intelligent Drug R-D Services Market Facts & Figures by Country (2018, 2023 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 BenevolentAI
10.1.1 BenevolentAI Company Details
10.1.2 BenevolentAI Business Overview
10.1.3 BenevolentAI Intelligent Drug R-D Services Introduction
10.1.4 BenevolentAI Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.1.5 BenevolentAI Recent Development
10.2 Exscientia
10.2.1 Exscientia Company Details
10.2.2 Exscientia Business Overview
10.2.3 Exscientia Intelligent Drug R-D Services Introduction
10.2.4 Exscientia Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.2.5 Exscientia Recent Development
10.3 IBM
10.3.1 IBM Company Details
10.3.2 IBM Business Overview
10.3.3 IBM Intelligent Drug R-D Services Introduction
10.3.4 IBM Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.3.5 IBM Recent Development
10.4 Alphabet
10.4.1 Alphabet Company Details
10.4.2 Alphabet Business Overview
10.4.3 Alphabet Intelligent Drug R-D Services Introduction
10.4.4 Alphabet Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.4.5 Alphabet Recent Development
10.5 Berg Health
10.5.1 Berg Health Company Details
10.5.2 Berg Health Business Overview
10.5.3 Berg Health Intelligent Drug R-D Services Introduction
10.5.4 Berg Health Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.5.5 Berg Health Recent Development
10.6 Atomwise
10.6.1 Atomwise Company Details
10.6.2 Atomwise Business Overview
10.6.3 Atomwise Intelligent Drug R-D Services Introduction
10.6.4 Atomwise Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.6.5 Atomwise Recent Development
10.7 Insitro
10.7.1 Insitro Company Details
10.7.2 Insitro Business Overview
10.7.3 Insitro Intelligent Drug R-D Services Introduction
10.7.4 Insitro Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.7.5 Insitro Recent Development
10.8 Cyclica
10.8.1 Cyclica Company Details
10.8.2 Cyclica Business Overview
10.8.3 Cyclica Intelligent Drug R-D Services Introduction
10.8.4 Cyclica Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.8.5 Cyclica Recent Development
10.9 NVIDIA
10.9.1 NVIDIA Company Details
10.9.2 NVIDIA Business Overview
10.9.3 NVIDIA Intelligent Drug R-D Services Introduction
10.9.4 NVIDIA Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.9.5 NVIDIA Recent Development
10.10 Insilico Medicine
10.10.1 Insilico Medicine Company Details
10.10.2 Insilico Medicine Business Overview
10.10.3 Insilico Medicine Intelligent Drug R-D Services Introduction
10.10.4 Insilico Medicine Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.10.5 Insilico Medicine Recent Development
10.11 AstraZeneca
10.11.1 AstraZeneca Company Details
10.11.2 AstraZeneca Business Overview
10.11.3 AstraZeneca Intelligent Drug R-D Services Introduction
10.11.4 AstraZeneca Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.11.5 AstraZeneca Recent Development
10.12 CAPGEMINI ENGINEERING
10.12.1 CAPGEMINI ENGINEERING Company Details
10.12.2 CAPGEMINI ENGINEERING Business Overview
10.12.3 CAPGEMINI ENGINEERING Intelligent Drug R-D Services Introduction
10.12.4 CAPGEMINI ENGINEERING Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.12.5 CAPGEMINI ENGINEERING Recent Development
10.13 Hafnium Labs ApS
10.13.1 Hafnium Labs ApS Company Details
10.13.2 Hafnium Labs ApS Business Overview
10.13.3 Hafnium Labs ApS Intelligent Drug R-D Services Introduction
10.13.4 Hafnium Labs ApS Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.13.5 Hafnium Labs ApS Recent Development
10.14 XtalPi Inc
10.14.1 XtalPi Inc Company Details
10.14.2 XtalPi Inc Business Overview
10.14.3 XtalPi Inc Intelligent Drug R-D Services Introduction
10.14.4 XtalPi Inc Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.14.5 XtalPi Inc Recent Development
10.15 Schrödinger
10.15.1 Schrödinger Company Details
10.15.2 Schrödinger Business Overview
10.15.3 Schrödinger Intelligent Drug R-D Services Introduction
10.15.4 Schrödinger Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.15.5 Schrödinger Recent Development
10.16 Charles River Laboratories
10.16.1 Charles River Laboratories Company Details
10.16.2 Charles River Laboratories Business Overview
10.16.3 Charles River Laboratories Intelligent Drug R-D Services Introduction
10.16.4 Charles River Laboratories Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.16.5 Charles River Laboratories Recent Development
10.17 IQVIA Inc
10.17.1 IQVIA Inc Company Details
10.17.2 IQVIA Inc Business Overview
10.17.3 IQVIA Inc Intelligent Drug R-D Services Introduction
10.17.4 IQVIA Inc Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.17.5 IQVIA Inc Recent Development
10.18 Healx
10.18.1 Healx Company Details
10.18.2 Healx Business Overview
10.18.3 Healx Intelligent Drug R-D Services Introduction
10.18.4 Healx Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.18.5 Healx Recent Development
10.19 Innoplexus
10.19.1 Innoplexus Company Details
10.19.2 Innoplexus Business Overview
10.19.3 Innoplexus Intelligent Drug R-D Services Introduction
10.19.4 Innoplexus Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.19.5 Innoplexus Recent Development
10.20 EVAXION BIOTECH A/S
10.20.1 EVAXION BIOTECH A/S Company Details
10.20.2 EVAXION BIOTECH A/S Business Overview
10.20.3 EVAXION BIOTECH A/S Intelligent Drug R-D Services Introduction
10.20.4 EVAXION BIOTECH A/S Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.20.5 EVAXION BIOTECH A/S Recent Development
10.21 Icometrix
10.21.1 Icometrix Company Details
10.21.2 Icometrix Business Overview
10.21.3 Icometrix Intelligent Drug R-D Services Introduction
10.21.4 Icometrix Revenue in Intelligent Drug R-D Services Business (2018-2023)
10.21.5 Icometrix Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Intelligent Drug R-D Services Market Size United States VS Global, CAGR (2018 VS 2023 VS 2033)
Table 2. Intelligent Drug R-D Services Market Trends
Table 3. Intelligent Drug R-D Services Market Drivers
Table 4. Intelligent Drug R-D Services Market Challenges
Table 5. Intelligent Drug R-D Services Market Restraints
Table 6. Global Intelligent Drug R-D Services Market Size by Type: 2018 VS 2023 VS 2033 (US$ Million)
Table 7. United States Intelligent Drug R-D Services Market Size by Type: 2018 VS 2023 VS 2033 (US$ Million)
Table 8. Global Intelligent Drug R-D Services Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 9. United States Intelligent Drug R-D Services Market Size by Application: 2018 VS 2023 VS 2033 (US$ Million)
Table 10. Global Key Companies of Intelligent Drug R-D Services, Ranked by Revenue (2023) & (US$ Million)
Table 11. Global Intelligent Drug R-D Services Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Intelligent Drug R-D Services Revenue Share by Player, 2018-2023
Table 13. Global Intelligent Drug R-D Services Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intelligent Drug R-D Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intelligent Drug R-D Services as of 2023)
Table 15. Global Key Players of Intelligent Drug R-D Services, Headquarters and Area Served
Table 16. Global Key Players of Intelligent Drug R-D Services, Product and Application
Table 17. Global Key Players of Intelligent Drug R-D Services, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Intelligent Drug R-D Services in United States, Ranked by Revenue (2023) & (US$ Million)
Table 20. United States Intelligent Drug R-D Services Revenue by Players, (US$ Million), 2021, 2023 & 2023
Table 21. United States Intelligent Drug R-D Services Revenue Share by Players, 2021, 2023 & 2023
Table 22. Global Intelligent Drug R-D Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 23. Global Intelligent Drug R-D Services Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Intelligent Drug R-D Services Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Intelligent Drug R-D Services Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Intelligent Drug R-D Services Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Intelligent Drug R-D Services Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Intelligent Drug R-D Services Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Intelligent Drug R-D Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 30. Americas Intelligent Drug R-D Services Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Intelligent Drug R-D Services Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Intelligent Drug R-D Services Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Intelligent Drug R-D Services Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Intelligent Drug R-D Services Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Intelligent Drug R-D Services Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Intelligent Drug R-D Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 37. EMEA Intelligent Drug R-D Services Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Intelligent Drug R-D Services Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Intelligent Drug R-D Services Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Intelligent Drug R-D Services Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Intelligent Drug R-D Services Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Intelligent Drug R-D Services Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Intelligent Drug R-D Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 44. APAC Intelligent Drug R-D Services Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Intelligent Drug R-D Services Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Intelligent Drug R-D Services Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Intelligent Drug R-D Services Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Intelligent Drug R-D Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 49. APAC Intelligent Drug R-D Services Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Intelligent Drug R-D Services Market Size by Region (2024-2033) & (US$ Million)
Table 51. BenevolentAI Company Details
Table 52. BenevolentAI Business Overview
Table 53. BenevolentAI Intelligent Drug R-D Services Product
Table 54. BenevolentAI Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 55. BenevolentAI Recent Development
Table 56. Exscientia Company Details
Table 57. Exscientia Business Overview
Table 58. Exscientia Intelligent Drug R-D Services Product
Table 59. Exscientia Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 60. Exscientia Recent Development
Table 61. IBM Company Details
Table 62. IBM Business Overview
Table 63. IBM Intelligent Drug R-D Services Product
Table 64. IBM Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 65. IBM Recent Development
Table 66. Alphabet Company Details
Table 67. Alphabet Business Overview
Table 68. Alphabet Intelligent Drug R-D Services Product
Table 69. Alphabet Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 70. Alphabet Recent Development
Table 71. Berg Health Company Details
Table 72. Berg Health Business Overview
Table 73. Berg Health Intelligent Drug R-D Services Product
Table 74. Berg Health Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 75. Berg Health Recent Development
Table 76. Atomwise Company Details
Table 77. Atomwise Business Overview
Table 78. Atomwise Intelligent Drug R-D Services Product
Table 79. Atomwise Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 80. Atomwise Recent Development
Table 81. Insitro Company Details
Table 82. Insitro Business Overview
Table 83. Insitro Intelligent Drug R-D Services Product
Table 84. Insitro Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 85. Insitro Recent Development
Table 86. Cyclica Company Details
Table 87. Cyclica Business Overview
Table 88. Cyclica Intelligent Drug R-D Services Product
Table 89. Cyclica Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 90. Cyclica Recent Development
Table 91. NVIDIA Company Details
Table 92. NVIDIA Business Overview
Table 93. NVIDIA Intelligent Drug R-D Services Product
Table 94. NVIDIA Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 95. NVIDIA Recent Development
Table 96. Insilico Medicine Company Details
Table 97. Insilico Medicine Business Overview
Table 98. Insilico Medicine Intelligent Drug R-D Services Product
Table 99. Insilico Medicine Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 100. Insilico Medicine Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Intelligent Drug R-D Services Product
Table 104. AstraZeneca Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. CAPGEMINI ENGINEERING Company Details
Table 107. CAPGEMINI ENGINEERING Business Overview
Table 108. CAPGEMINI ENGINEERING Intelligent Drug R-D Services Product
Table 109. CAPGEMINI ENGINEERING Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 110. CAPGEMINI ENGINEERING Recent Development
Table 111. Hafnium Labs ApS Company Details
Table 112. Hafnium Labs ApS Business Overview
Table 113. Hafnium Labs ApS Intelligent Drug R-D Services Product
Table 114. Hafnium Labs ApS Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 115. Hafnium Labs ApS Recent Development
Table 116. XtalPi Inc Company Details
Table 117. XtalPi Inc Business Overview
Table 118. XtalPi Inc Intelligent Drug R-D Services Product
Table 119. XtalPi Inc Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 120. XtalPi Inc Recent Development
Table 121. Schrödinger Company Details
Table 122. Schrödinger Business Overview
Table 123. Schrödinger Intelligent Drug R-D Services Product
Table 124. Schrödinger Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 125. Schrödinger Recent Development
Table 126. Charles River Laboratories Company Details
Table 127. Charles River Laboratories Business Overview
Table 128. Charles River Laboratories Intelligent Drug R-D Services Product
Table 129. Charles River Laboratories Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 130. Charles River Laboratories Recent Development
Table 131. IQVIA Inc Company Details
Table 132. IQVIA Inc Business Overview
Table 133. IQVIA Inc Intelligent Drug R-D Services Product
Table 134. IQVIA Inc Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 135. IQVIA Inc Recent Development
Table 136. Healx Company Details
Table 137. Healx Business Overview
Table 138. Healx Intelligent Drug R-D Services Product
Table 139. Healx Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 140. Healx Recent Development
Table 141. Innoplexus Company Details
Table 142. Innoplexus Business Overview
Table 143. Innoplexus Intelligent Drug R-D Services Product
Table 144. Innoplexus Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 145. Innoplexus Recent Development
Table 146. EVAXION BIOTECH A/S Company Details
Table 147. EVAXION BIOTECH A/S Business Overview
Table 148. EVAXION BIOTECH A/S Intelligent Drug R-D Services Product
Table 149. EVAXION BIOTECH A/S Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 150. EVAXION BIOTECH A/S Recent Development
Table 151. Icometrix Company Details
Table 152. Icometrix Business Overview
Table 153. Icometrix Intelligent Drug R-D Services Product
Table 154. Icometrix Revenue in Intelligent Drug R-D Services Business (2018-2023) & (US$ Million)
Table 155. Icometrix Recent Development
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Intelligent Drug R-D Services Product Picture
Figure 2. Global Intelligent Drug R-D Services Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global Intelligent Drug R-D Services Market Size 2018-2033 (US$ Million)
Figure 4. United States Intelligent Drug R-D Services Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 5. United States Intelligent Drug R-D Services Market Size 2018-2033 (US$ Million)
Figure 6. United States Intelligent Drug R-D Services Market Share in Global 2018-2033
Figure 7. Intelligent Drug R-D Services Report Years Considered
Figure 8. Product Picture of Cloud Based
Figure 9. Product Picture of On-Premise
Figure 10. Global Intelligent Drug R-D Services Market Share by Type in 2023 & 2033
Figure 11. Global Intelligent Drug R-D Services Market Size by Type (2018-2033) & (US$ Million)
Figure 12. Global Intelligent Drug R-D Services Market Share by Type (2018-2033)
Figure 13. United States Intelligent Drug R-D Services Market Share by Type in 2023 & 2033
Figure 14. United States Intelligent Drug R-D Services Market Size by Type (2018-2033) & (US$ Million)
Figure 15. United States Intelligent Drug R-D Services Market Share by Type (2018-2033)
Figure 16. Product Picture of Drug Discovery Research
Figure 17. Product Picture of Drug Development Research
Figure 18. Product Picture of Clinical Research
Figure 19. Global Intelligent Drug R-D Services Market Share by Application in 2023 & 2033
Figure 20. Global Intelligent Drug R-D Services Market Size by Application (2018-2033) & (US$ Million)
Figure 21. Global Intelligent Drug R-D Services Market Share by Application (2018-2033)
Figure 22. United States Intelligent Drug R-D Services Market Share by Application in 2023 & 2033
Figure 23. United States Intelligent Drug R-D Services Market Size by Application (2018-2033) & (US$ Million)
Figure 24. United States Intelligent Drug R-D Services Market Share by Application (2018-2033)
Figure 25. The Top 5 and 10 Largest Companies of Intelligent Drug R-D Services in the World: Market Share by Intelligent Drug R-D Services Revenue in 2023
Figure 26. Global Intelligent Drug R-D Services Market Size Market Share by Region: 2018 VS 2023 VS 2033
Figure 27. Global Intelligent Drug R-D Services Market Share by Region (2018-2033)
Figure 28. Americas Intelligent Drug R-D Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 29. Americas Intelligent Drug R-D Services Market Share by Type (2018-2033)
Figure 30. Americas Intelligent Drug R-D Services Market Share by Application (2018-2033)
Figure 31. United States Intelligent Drug R-D Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 32. Canada Intelligent Drug R-D Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Mexico Intelligent Drug R-D Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Brazil Intelligent Drug R-D Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. EMEA Intelligent Drug R-D Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 36. EMEA Intelligent Drug R-D Services Market Share by Type (2018-2033)
Figure 37. EMEA Intelligent Drug R-D Services Market Share by Application (2018-2033)
Figure 38. Europe Intelligent Drug R-D Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 39. Middle East Intelligent Drug R-D Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Africa Intelligent Drug R-D Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. China Intelligent Drug R-D Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 42. China Intelligent Drug R-D Services Market Share by Type (2018-2033)
Figure 43. China Intelligent Drug R-D Services Market Share by Application (2018-2033)
Figure 44. APAC Intelligent Drug R-D Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 45. APAC Intelligent Drug R-D Services Market Share by Type (2018-2033)
Figure 46. APAC Intelligent Drug R-D Services Market Share by Application (2018-2033)
Figure 47. Japan Intelligent Drug R-D Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 48. South Korea Intelligent Drug R-D Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. China Taiwan Intelligent Drug R-D Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Intelligent Drug R-D Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. India Intelligent Drug R-D Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. BenevolentAI Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 53. Exscientia Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 54. IBM Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 55. Alphabet Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 56. Berg Health Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 57. Atomwise Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 58. Insitro Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 59. Cyclica Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 60. NVIDIA Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 61. Insilico Medicine Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 62. AstraZeneca Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 63. CAPGEMINI ENGINEERING Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 64. Hafnium Labs ApS Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 65. XtalPi Inc Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 66. Schrödinger Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 67. Charles River Laboratories Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 68. IQVIA Inc Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 69. Healx Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 70. Innoplexus Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 71. EVAXION BIOTECH A/S Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 72. Icometrix Revenue Growth Rate in Intelligent Drug R-D Services Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries